SWITDAPA M (Dapagliflozin (10mg) + Metformin (500mg))

Switdapa-M 10/500 XR Tablet is formulated from two active ingredients aimed at managing type 2 diabetes mellitus. This medication assists in regulating elevated blood sugar levels commonly associated with diabetes, thereby decreasing the risk of severe complications linked to the condition, including cardiovascular issues. It is recommended to take Switdapa-M 10/500 XR with food to enhance its effectiveness. Maintaining a routine by taking the tablet at the same time each day can aid in adherence to the treatment regimen. The specific dosage should be determined by your healthcare provider, and it is essential not to discontinue usage without prior consultation as this could lead to a spike in blood sugar levels and increase the risk of serious complications such as kidney impairment and vision loss. It is important to understand that this medication is part of a comprehensive management strategy that should also involve a balanced diet, consistent physical activity, and weight management as directed by a healthcare professional. Staying well-hydrated can help prevent dehydration, which may occur with the use of this medication. Some individuals might experience fungal infections in the genital area, and maintaining personal hygiene is crucial in prevention. Prior to starting this medication, discuss any existing kidney or liver issues, urinary tract infections, or use of diuretics with your doctor. Pregnant and breastfeeding individuals should seek medical advice before initiating treatment. Regular monitoring of blood sugar levels is advised while using this medication.